{"nct_id":"NCT01828021","title":"Phase 2 Study of the Monoclonal Antibody MGAH22 (Margetuximab) in Patients With Relapsed or Refractory Advanced Breast Cancer","status":"COMPLETED","status_verified_date":"2025-02","start_date":"2013-03","start_date_type":"ACTUAL","primary_completion_date":"2016-12-07","primary_completion_date_type":"ACTUAL","completion_date":"2017-04-14","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["MGNX"]}